Join colleagues, health providers and researchers online for the inaugural 2023 Biomedical Diagnostics Discussion Series in collaboration with Thermo Fisher Scientific, a three-part series starting June 14, with two more sessions coming in the fall.
What are the pros and cons of diagnostic screening from cancer to COVID-19 and beyond. Which tests are being over and underutilized? How can screening be economically feasible? Will we ever have effective screening tests from a single drop of blood?
Karen Anderson, MD, PhD
Professor
Biodesign Center for Personalized Diagnostics
Arizona State University
Associate professor of medicine
Mayo Clinic
Bruce J. Tromberg, PhD
Director
National Institute of Biomedical Imaging and Bioengineering
National Institutes of Health
Christina Clarke Dur, PhD
Epidemiology vice president
Distinguished scientist
GRAIL, Inc.
Mara Aspinall, moderator
Professor of practice
ASU College of Health Solutions